MedTrace Logo

Corneal Densitometry Changes With Adenoviral SEI

NCT04267991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2020-05-29

No results posted yet for this study

Summary

Adenoviral Sub epithelial infiltrates (SEI) affect ocular function.They lead to reduced vision, photophobia, glare, halos, and foreign body sensation.

Conditions

  • Corneal Disease

Interventions

DRUG

Tacrolimus ointment

Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.

PROCEDURE

phototherapeutic keratectomy

Patients underwent transepithelial PTK for subepithelial infiltrates.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • TAREK R ELHAMAKY · Benha university faculty of medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-04-01
Completion
2020-04-15
FDA Drug
Yes

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267991 on ClinicalTrials.gov